BioMarin Pharmaceutical Inc. Share Price
NASDAQ: BMRN | Large CapBioMarin Pharmaceutical Inc. Stock Performance
BioMarin Pharmaceutical Inc. Share Price Today
As of 31 October 2026, BioMarin Pharmaceutical Inc.'s share price is $58.54. The stock opened at $58.99, compared to its previous close of $57.47. During today's trading session, BioMarin Pharmaceutical Inc.'s share price traded between $57.88 and $59.13, with an average price of $58.51. Over the past 52 weeks, the stock has recorded a high of $70.98 and a low of $49.29. In terms of performance, BioMarin Pharmaceutical Inc.'s share price has risen by 8.56% over the last six months and is up 9.22% on a year-on-year basis.
BioMarin Pharmaceutical Inc. Share Price Chart
BioMarin Pharmaceutical Inc. Quarterly Profit & Loss
All figures in USD
BioMarin Pharmaceutical Inc. Annual Profit & Loss
All figures in USD
About BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
BioMarin Pharmaceutical Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $59.81 | $58.51 | -2.55% |
Sep 2026 | $65.58 | $60.04 | -8.07% |
Aug 2026 | $60.41 | $65.31 | +8.81% |
Jul 2026 | $57.46 | $60.02 | +4.86% |
Jun 2026 | $56.67 | $57.24 | -0.16% |
May 2026 | $53.84 | $57.33 | +6.31% |
Apr 2026 | $56.91 | $53.92 | -4.52% |
Mar 2026 | $60.77 | $56.48 | -8.49% |
Feb 2026 | $56.52 | $61.72 | +9.17% |
Jan 2026 | $59.05 | $56.53 | -4.89% |
Dec 2025 | $55.56 | $59.44 | +6.33% |
Nov 2025 | $53.27 | $55.90 | +4.29% |